HomeCategoryPharmaceuticals Archives -

Philippines: New Guidelines for health products recall

Philippines: New Guidelines for health products recall   Philippines have published Guidelines on the Recall of Health Products Regulated by the Food and Drug Administration. The regulatory landscape of health products has changed significantly in Philippines, therefore the initially issued Guidelines on Product Recall needs to be revised. A Circular was promulgated to create an...

Korea: Amendments to the Regulations on Safety of Pharmaceuticals

Korea: Amendments to the Regulations on Safety of Pharmaceuticals   South Korea published new amendments to its Regulations on Safety of Pharmaceuticals, proposed by the Ministry of Food and Drug Safety (MFDS) in the Notification No. 2023-550 of 29 November 2023. The amendments include: Improvement of regulations related to submission for Marketing Authorization (revision of...

EU: New pharmaceutical legislation published

EU: New pharmaceutical legislation published   EU published a proposal for a Regulation laying down Union procedures for the authorisation and supervision of medicinal products. The Regulation would also establishe rules and procedures at Union and at Member State level relating to the security of supply of medicinal products and lays down the governance provisions...

Philippines: Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price (MRP)

Philippines: Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price (MRP)   Philippines has published Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price (MRP). The proposed Guidelines aim to provide streamlined and rational application  process  for  the  change  of  labeling  materials  under  MRP  including  drug molecules or drug formula that...

EU: Derogations for medicinal products from the United Kingdom

EU: Derogations for medicinal products from the United Kingdom   The EU Commission has published a Proposal for a Directive of the European Parliament and of the Council amending Directives 2001/20/EC and 2001/83/EC as regards derogations from certain obligations concerning certain medicinal products for human use made available in the United Kingdom in respect of...

Philippines: Revision of the Guidelines on Good Manufacturing Practice (GMP) Clearance for Foreign Drug Manufacturers

Philippines: Revision of the Guidelines on Good Manufacturing Practice (GMP) Clearance for Foreign Drug Manufacturers   Philippines has published a new draft Administrative Order concerning Revised Guidelines on Good Manufacturing Practice (GMP) Clearance for Foreign Drug Manufacturers. The purpose of the revision is to update the current guidelines on the Foreign GMP Clearance requirements and...

Singapore: Health Products (Therapeutic Products) Regulations

Singapore: Health Products (Therapeutic Products) Regulations   Singapore has published Health Products (Therapeutic Products) Regulations – Presentation of Therapeutic Products regulations 19 and 20 and Guidance on Therapeutic Product Registration in Singapore: Applicable labelling requirements in Appendix 7 on Points to consider for Singapore Labelling. Therapeutic products in Singapore are subject to labelling requirements that...

Russia: Draft guideline for the pharmaceutical development of medicinal products for use in paediatric practice

Russia: Draft guideline for the pharmaceutical development of medicinal products for use in paediatric practice   Russia has published a Draft guideline for the pharmaceutical development of medicinal products for use in paediatric practice. The draft guideline on the pharmaceutical development of medicines for use in paediatric practice provides for the need to establish unified...

https://www.productcomplianceinstitute.com/wp-content/uploads/2025/03/logo-no-background-1.png
Atrium Centrum, Al. Jana Pawła II 27, 00-867 Warsaw
Kunstlaan / Avenue des Arts 56, Brussels
+48 575 570 017

Follow us:

The content provided on this website is not intended to and does not constitute legal advice. Submissions or postings to the website are not confidential. We do not warrant or guarantee the accuracy, completeness or adequacy of the content. Your use of the content on the website or materials linked from this website is at your own risk.

Copyright © Product Compliance Institute 2025

en_USEnglish